Effects of catechol-O-methyltransferase (COMT) inhibition on the pharmacokinetics of L-DOPA.
Nutt
J G
JG
Department of Neurology, School of Medicine, Oregon Health Sciences University, Portland 97201-3098, USA.
D000978:Antiparkinson Agents / Q000493:pharmacokinetics*; D001921:Brain / Q000378:metabolism; D065098:Catechol O-Methyltransferase Inhibitors; D004347:Drug Interactions; D006801:Humans; D007980:Levodopa / Q000493:pharmacokinetics*; D014018:Tissue Distribution
D000978:Antiparkinson Agents; D065098:Catechol O-Methyltransferase Inhibitors; D007980:Levodopa